Overview
Introduction
Two maternity immunizations are heavily tested because their timing, route, and contraindications are precise: Rho(D) immune globulin, often called RhoGAM, and the rubella vaccine.
Two maternity immunizations are heavily tested because their timing, route, and contraindications are precise: Rho(D) immune globulin, often called RhoGAM, and the rubella vaccine. RhoGAM prevents an Rh-negative client from forming antibodies against Rh-positive fetal blood, protecting future pregnancies from hemolytic disease of the fetus and newborn. The rubella vaccine protects future pregnancies from congenital rubella syndrome by immunizing non-immune clients postpartum. The nurse must apply each at the correct time, by the correct route, to the correct client. The stakes are high because errors are subtle. Giving RhoGAM by the wrong route, missing the 72-hour postpartum window, or giving it to an already-sensitized client all defeat its purpose. Giving the live rubella vaccine during pregnancy, or failing to teach contraception afterward, risks fetal harm. Consider a case: you are the nurse caring for an Rh-negative, antibody-negative client who has just delivered an Rh-positive infant. Which action protects future pregnancies? You confirm the blood type and antibody screen and administer RhoGAM intramuscularly within 72 hours of delivery, documenting the time, because that window is strict and the route is never...